News – Page 917 – Endpoints News

Cancer drugs among US goods spared from tariffs as China issues first exemptions in trade war

6 years ago

Tocagen shares collapse as investigators read last rites for PhIII brain cancer study

6 years ago

Look out Alexion, Roche breaks out the details on its rival rare CNS drug

6 years ago

The mRNA unicorn Moderna has more early-stage human data it wants to show off — reaching new peaks in proving the ...

6 years ago

Atomwise inks China deal as list of AI collaborations lengthens

6 years ago

Investors lost big as Alzheimer’s R&D went over the cliff in 2019. Will they ever come back?

6 years ago

Big Pharma joins £200M UK Biobank sequencing project; Monopar sets terms for $40M IPO

6 years ago

Promising autoimmune biotech bought out as celiac drug heads for the clinic with a fresh infusion of cash

6 years ago

How about a $477M biotech IPO amid Hong Kong protests? Henlius will find out

6 years ago

No surprises in FDA staff review for Aimmune peanut allergy therapy — focus remains on safety, tolerability profile

6 years ago

Merck KGaA touts FDA 'breakthrough' status, blockbuster potential in bid to woo investors

6 years ago

Woodford fallout to blame for shrinking biotech valuations, co-investor says

6 years ago

Hong Kong strife holds up almost $100M of BioNTech's Series B haul

6 years ago

After plenty of due diligence, GSK buys one biotech pup in the ‘$500M’ Avalon litter for its pipeline

6 years ago

FDA developing guidance on real-world data quality issues, officials say

6 years ago

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

6 years ago

Sanofi takes a $260M hit to extricate itself from a disastrous alliance with Lexicon

6 years ago

The Endpoints 100: Novartis gets 'poor' grade on data scandal, Ned Sharpless isn't a 'wow' and that Canada drug ...

6 years ago

Atomwise, OncoStatyx launch JV to target triple-negative breast cancer; Cancer biotech woos former Spark COO John ...

6 years ago

After BioCryst fizzle, a new oral HAE player emerges

6 years ago

Australian cell therapy company Mesoblast joins forces with Germany's Grünenthal to tackle low back pain

6 years ago

Shedding non-core units while loading up on cash, Mallinckrodt bags $250M in CDMO sale

6 years ago

A new player jumps into the heated race for a sickle cell cure, with help from Google's GV

6 years ago

Alex Zhavoronkov follows landmark AI paper with $37M round for Insilico featuring top-notch China VCs

6 years ago

First page Previous page 914 915 916917918 919 920 Next page Last page